FIRALIS S.A BRIDGING SCIENCE TO CLINICS

Founded in 2008 in Huningue (Basel neighbourhood), Firalis is a biotechnology company active in the discovery, development and qualification of biomarkers (BM) to improve diagnostic results and personalized medicine for clinical applications. Firalis develops biomarkers and biomarker-based diagnostic kits to improve disease outcomes, patient comfort and therapeutic decisions. The research
activities are oriented towards multiple therapeutic areas, such as Cardiovascular (Heart Failure), Inflammation & Auto Immune diseases and Neurology ( Alzheimer).
Service of Biobank
Olink Proteomics certified service provider
HTG molecular qualified service provider in Europe
Propel Certification NGS illumina

News Release: Firalis launched Biopred Panel

272 products